
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 44
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT02597868 | A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep) | ||
NCT06715982 | JAK Inhibitors for Solid Malignant Tumor Patients with Immune Checkpoint Inhibitors-related Dermatitis: a Open-lable, Single Arm, Phase IIa Trial | ||
NCT02607982 | CCRT for Esophageal Cancer. | ||
NCT06078930 | Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms | ||
NCT04910594 | Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma | ||
NCT03058094 | A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI | ||
NCT01404260 | Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer | ||
NCT03200691 | Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma | ||
NCT03639896 | Endothelial Injury Mechanism in Elderly Patients Undergoing Major Surgery | ||
NCT03554889 | Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells | ||
NCT05028439 | RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma | ||
NCT04911517 | Neoadjuvant Chemoradiotherapy Plus Tislelizumab Followed by TME for LARC. | ||
NCT02503150 | Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer | ||
NCT01918241 | Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia | ||
NCT03236636 | The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects | ||
NCT03178136 | HR-HPV Multi-site Opportunistic Screening in Liaoning, China | ||
NCT06462313 | Dobutamine for Management of Surgical Patients with Septic Shock | ||
NCT05588206 | Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer | ||
NCT03792542 | Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy | ||
NCT03123770 | Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients | ||
NCT03187314 | Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer | ||
NCT03011255 | Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer | ||
NCT04517214 | Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma | ||
NCT04920214 | Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC | ||
NCT02385136 | Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases | ||
NCT01616849 | Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma | ||
NCT04481100 | CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer | ||
NCT04921085 | Nutritional Status Study of Inpatients in Hospitals | ||
NCT06713421 | Effect of Premedication With Pronase on Mucosal Cleanliness During EGD | ||
NCT04720521 | Application of OE in Diagnosis of EGC | ||
NCT01637493 | Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients | ||
NCT03661671 | Application of Linked Color Imaging(LCI) in Diagnosis of Early Gastric Cancer(EGC) | ||
NCT03374293 | Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer | ||
NCT03081715 | PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer | ||
NCT02544737 | Apatinib for Metastatic Esophageal Cancer. | ||
NCT02738983 | RT Plus EGFR-TKI for Wild-type NSCLC | ||
NCT04636593 | A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC | ||
NCT06164561 | 18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study. | ||
NCT02745561 | Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. | ||
NCT04030845 | Patient Report Outcome-Reconstruction and Oncoplastic Cohort | ||
NCT02545751 | SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer | ||
NCT05520853 | SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC | ||
NCT01815853 | Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer | ||
NCT05749445 | Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients |